Soiken Holdings Inc.
Notice of Dissolution of Subsidiary
The news reports the resolution to dissolve BB Laboratories (BBL), the subsidiary. All business to be terminated by March 31, 2026, liquidation not yet decided, and financial impact expected to be minor in the fiscal year ending June 2027.
Key Figures
- BBL dissolution date: 2026-08-12
- Transfer completion to NYI: 2026-03-01
- Business termination date: 2026-03-31
AI要約
Overview of the business reorganization
This notice reports the dissolution resolution of BBL as part of the structural reform of the group, which centers on the healthcare business, including withdrawal from BBL, termination of all businesses, and transfer of the cosmetics business to NYI. The transfer to NYI was completed on March 1, 2026, all businesses were terminated on March 31, and dissolution was reached.
Outlook and impact
Liquidation associated with the dissolution is not yet determined, and the impact on the 2027 fiscal year is expected to be minor. The key indicators show trends for the most recent three fiscal years, but the impact from the business termination is described as limited.
Total Medical Research Holdings Co., Ltd.
Company overview · Stock price · Financial data · All IR
